Study of Choline Chloride for Injection in Adolescent and Adult Patients With Intestinal Failure Receiving Long Term Parenteral Support
Mar 18, 2025
―
Tara-002
Non-Muscle Invasive Bladder Cancer
Phase II
Recruiting
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
Jun 29, 2023
―
Tara-002
Lymphatic Malformation
Phase II
Recruiting
Safety and Efficacy Study of Intracystic TARA-002 for the Treatment of Lymphatic Malformations in Participants 6 Months to Less Than 18 Years of Age
May 11, 2023
―
Tara-002
Non-Muscle Invasive Bladder Cancer
Phase I
Completed
Safety and Toxicity Study of Intravesical Instillation of TARA-002 in Adults with High-grade Non-muscle Invasive Bladder Cancer (Phase 1a)
Oct 07, 2021
―
Tara-002
Non-Muscle Invasive Bladder Cancer
Phase I
Completed
Safety and Toxicity Study of Intravesical Instillation of TARA-002 in Adults with High-grade Non-muscle Invasive Bladder Cancer (Phase 1b)
Oct 07, 2021
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Protara Therapeutics, Inc. (TARA) have in its pipeline
TARA is currently developing the following drugs: Choline Chloride For Injection, Tara-002, Tara-002. These drug candidates are in various stages of clinical development as the company works toward FDA approval.